Levodopa therapeutics for Parkinson's disease: new developments

Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S31-4. doi: 10.1016/S1353-8020(09)70009-4.

Abstract

Levodopa serves as the gold standard of anti-parkinsonian therapy and nearly every patient with Parkinson's disease eventually receives this drug. To improve upon levodopa therapy, several forms of treatment have been devised to augment its actions, and new delivery systems are under development. This new research offers promise for improving outcomes with this highly effective therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Drug Delivery Systems / methods
  • Drug Delivery Systems / trends
  • Humans
  • Levodopa / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology

Substances

  • Antiparkinson Agents
  • Levodopa